S&P 500
(0.60%) 5 158.55 points
Dow Jones
(0.36%) 38 815 points
Nasdaq
(0.61%) 16 255 points
Oil
(0.70%) $78.66
Gas
(3.17%) $2.21
Gold
(1.20%) $2 336.30
Silver
(3.15%) $27.53
Platinum
(0.78%) $972.85
USD/EUR
(-0.19%) $0.927
USD/NOK
(-0.55%) $10.81
USD/GBP
(-0.30%) $0.795
USD/RUB
(-0.06%) $91.39

Echtzeitaktualisierungen für Hypera S.A. [HYPMY]

Börse: OTC Sektor: Healthcare Industrie: Drug Manufacturers—Specialty & Generic
Zuletzt aktualisiert6 Mai 2024 @ 15:51

0.45% $ 5.96

Live Chart Being Loaded With Signals

Commentary (6 Mai 2024 @ 15:51):

Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex – A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands...

Stats
Tagesvolumen 1 081.00
Durchschnittsvolumen 10 468.00
Marktkapitalisierung 3.77B
EPS $0.782 ( 2023-09-30 )
Nächstes Ertragsdatum ( $0 ) 2024-07-25
Last Dividend $0.0640 ( 2023-07-06 )
Next Dividend $0 ( N/A )
P/E 11.69
ATR14 $0 (0.00%)

Hypera S.A. Korrelation

10 Am meisten positiv korreliert
10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Hypera S.A. Finanzdaten

Annual 2023
Umsatz: $7.91B
Bruttogewinn: $4.85B (61.30 %)
EPS: $2.61
FY 2023
Umsatz: $7.91B
Bruttogewinn: $4.85B (61.30 %)
EPS: $2.61
FY 2022
Umsatz: $7.55B
Bruttogewinn: $4.76B (63.10 %)
EPS: $2.68
FY 2021
Umsatz: $5.94B
Bruttogewinn: $3.80B (64.05 %)
EPS: $2.11

Financial Reports:

No articles found.

Hypera S.A. Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0.0590
(N/A)
$0.117
(N/A)
$0
(N/A)
$0.0590
(N/A)
$0.0640
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Hypera S.A. Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 9.59 - good (95.91%) | Divividend Growth Potential Score: 5.91 - Stable (18.27%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.0770 2011-05-10
Last Dividend $0.0640 2023-07-06
Next Dividend $0 N/A
Payout Date 2023-09-09
Next Payout Date N/A
# dividends 30 --
Total Paid Out $2.45 --
Avg. Dividend % Per Year 0.00% --
Score 4.13 --
Div. Sustainability Score 9.59
Div.Growth Potential Score 5.91
Div. Directional Score 7.75 --
Next Divdend (Est)
(2024-10-23)
$0.0654 Estimate 12.14 %
Dividend Stability
0.49 Below Average
Dividend Score
4.13
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for OTC

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
SPKKY Ex Dividend Knight 2023-09-14 Annually 0 0.00%
GTPS Ex Dividend Knight 2023-09-14 Quarterly 0 0.00%
AGESY Ex Dividend Junior 2023-10-25 Annually 0 0.00%
NIDB Ex Dividend Knight 2023-08-10 Bi-Monthly 0 0.00%
CNTHO Ex Dividend Knight 2023-09-07 Quarterly 0 0.00%
TKAGY Ex Dividend Junior 2023-06-12 Annually 0 0.00%
HWDJY Ex Dividend Knight 2023-10-12 Annually 0 0.00%
ASCCY Ex Dividend Junior 2023-06-28 Annually 0 0.00%
PNBI Ex Dividend Knight 2023-09-14 Quarterly 0 0.00%
DTCWY Ex Dividend Junior 2023-06-15 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.2121.5005.778.65[0 - 0.5]
returnOnAssetsTTM0.06041.2007.999.58[0 - 0.3]
returnOnEquityTTM0.1491.5009.4510.00[0.1 - 1]
payoutRatioTTM0.0801-1.0009.20-9.20[0 - 1]
currentRatioTTM1.8070.8005.974.77[1 - 3]
quickRatioTTM1.3140.8006.985.58[0.8 - 2.5]
cashRatioTTM0.6621.5007.4310.00[0.2 - 2]
debtRatioTTM0.378-1.5003.69-5.54[0 - 0.6]
interestCoverageTTM2.281.000-0.266-0.266[3 - 30]
operatingCashFlowPerShareTTM3.082.008.9710.00[0 - 30]
freeCashFlowPerShareTTM1.8662.009.0710.00[0 - 20]
debtEquityRatioTTM0.910-1.5006.36-9.54[0 - 2.5]
grossProfitMarginTTM0.6151.0003.093.09[0.2 - 0.8]
operatingProfitMarginTTM0.3271.0005.455.45[0.1 - 0.6]
cashFlowToDebtRatioTTM0.1831.000-0.0935-0.0935[0.2 - 2]
assetTurnoverTTM0.2860.800-1.429-1.143[0.5 - 2]
Total Score9.59

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM11.201.0008.970[1 - 100]
returnOnEquityTTM0.1492.509.6510.00[0.1 - 1.5]
freeCashFlowPerShareTTM1.8662.009.3810.00[0 - 30]
dividendYielPercentageTTM0.1781.5005.560[0 - 0.4]
operatingCashFlowPerShareTTM3.082.008.9710.00[0 - 30]
payoutRatioTTM0.08011.5009.20-9.20[0 - 1]
pegRatioTTM0.03941.500-3.070[0.5 - 2]
operatingCashFlowSalesRatioTTM0.2431.0006.430[0.1 - 0.5]
Total Score5.91

Hypera S.A.

Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex – A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands. The company also provides dermo-cosmetics products under the Mantecorp Skincare brands; and consumer health products under the Apracur, Benegrip, Coristina d, Engov, Epocler, Estomazil, and other brands. In addition, it offers nutritional and vitamin supplement products under the Tamarine, Vitasay, Biotônico Fontoura, and Zero-Cal brands; and similar and generic medicines under the Neo Química, Sodium Diclofenac, Hydroxyzine, Dipyron, Ibuprofen, Losartan Potassium, Mal Dexchlorpheniramine, Naproxene, Paracetamol, Simethicon, Loratadine, Omeprazole, Tadalaphyl, and Desogestrel brand names. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. is based in São Paulo, Brazil.

Über Live-Signale

Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.

Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.